TELA Bio, Inc.

TELA ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $50.8M $52.7M $46.7M $42.0M $43.9M $74.4M $45.3M $17.3M
Accounts Receivable $10.3M $10.1M $9.7M $6.6M $4.2M $2.7M $2.8M $1.3M
Inventory $11.0M $12.8M $13.2M $11.8M $7.7M $3.9M $4.6M $4.3M
Total Current Assets $75.6M $78.1M $71.7M $62.4M $59.1M $83.2M $64.3M $23.3M
Property, Plant & Equipment $2.2M $2.3M $2.0M $1.7M $1.2M $626.0K $677.0K $758.0K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) $1.4M $1.7M $2.1M $2.5M $2.3M $2.6M $2.9M —
Total Assets $81.4M $86.6M $78.0M $67.9M $62.5M $86.5M $67.9M $27.2M
Liabilities
Accounts Payable $2.3M $2.1M $1.7M $1.5M $2.4M $652.0K $3.2M $3.4M
Total Current Liabilities $18.0M $15.6M $17.0M $12.4M $10.6M $6.6M $6.7M $9.6M
Long-Term Debt $55.7M $41.1M $40.5M $39.9M $31.5M $30.8M $30.2M —
Total Liabilities $75.1M $58.1M $59.2M $53.6M $42.4M $37.4M $37.0M $40.9M
Stockholders' Equity
Retained Earnings $-397.6M $-358.7M $-320.9M $-274.2M $-229.9M $-196.7M $-167.9M $-137.9M
Total Stockholders' Equity $6.3M $28.5M $18.9M $14.3M $20.1M $49.0M $31.0M $-137.9M